Radboud University Medical Center
π³π±Netherlands
- Country
- π³π±Netherlands
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.radboudumc.nl
Phenotyping of High Dose Rifampicin
Phase 1
Completed
- Conditions
- Tuberculosis
- Interventions
- Combination Product: phenotyping cocktail
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2021-08-17
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT04525235
- Locations
- πΏπ¦
TASK, Cape Town, South Africa
πΏπ¦UCT lung institute, Cape Town, South Africa
Trajectory of Neuroinflammatory Markers in Cerebrospinal Fluid Prior to and After Thoracic Aortic Surgery
Recruiting
- Conditions
- Thoracic Aortic AneurysmPostoperative Cognitive DysfunctionPostoperative Delirium
- Interventions
- Diagnostic Test: Trajectory of neuroinflammatory proteins in CSF and blood
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT04523909
- Locations
- π³π±
Department of Intensive Care Medicine, Radboud university medical center, Nijmegen, Netherlands
Neuroinflammation in Cognitive Decline Post-cardiac Surgery
Completed
- Conditions
- Coronary Artery DiseasePostoperative Cognitive DysfunctionPathophysiology
- Interventions
- Diagnostic Test: 18F-DPA-714 PET/CT neuroimaging
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2023-03-31
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT04520802
- Locations
- π³π±
Department of Intensive Care Medicine, Radboud university medical center, Nijmegen, Netherlands
The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19
Not Applicable
Completed
- Conditions
- Post Intensive Care Unit SyndromeCoronavirus
- Interventions
- Device: Virtual Reality
- First Posted Date
- 2020-08-10
- Last Posted Date
- 2021-04-06
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 48
- Registration Number
- NCT04505761
- Locations
- π³π±
Radboud university medical center, Nijmegen, Gelderland, Netherlands
18F-PSMA-1007 PET Imaging to Detect Primary Prostate Cancer
Phase 1
Completed
- Conditions
- Prostate Cancer
- Interventions
- Diagnostic Test: 18F-PSMA-1007 PET/CT
- First Posted Date
- 2020-07-27
- Last Posted Date
- 2025-01-16
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 75
- Registration Number
- NCT04487847
- Locations
- π³π±
Radboud University, Nijmegen, Netherlands
The Natural History of Patients With Mutations in SEPN1 (SELENON) or LAMA2
Completed
- Conditions
- MDC1ASELENON-related Myopathy
- Interventions
- Other: No intervention
- First Posted Date
- 2020-07-21
- Last Posted Date
- 2023-11-18
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 38
- Registration Number
- NCT04478981
- Locations
- π³π±
Radboudumc, Nijmegen, Gelderland, Netherlands
Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.
Recruiting
- Conditions
- Infection, BacterialCritically IllSepsisSeptic Shock
- Interventions
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT04470973
- Locations
- π³π±
Radboudumc intensive care, Nijmegen, Netherlands
STOP OVarian CAncer; Implementation of the Opportunistic Salpingectomy in the Netherlands
Active, not recruiting
- Conditions
- Ovarian CancerRisk Reduction
- Interventions
- Procedure: Opportunistic Salpingectomy
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2024-01-26
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 10000
- Registration Number
- NCT04470921
- Locations
- π³π±
Erasmus Medical Center, Rotterdam, Netherlands
π³π±Elisabeth-Tweesteden Hospital, Tilburg, Netherlands
π³π±Diakonessenhuis, Utrecht, Netherlands
Influence of COVID-19 on Vascular Endothelial Function
- Conditions
- COVIDVascular; Damage
- First Posted Date
- 2020-07-13
- Last Posted Date
- 2022-01-19
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 203
- Registration Number
- NCT04468412
- Locations
- π³π±
Bernhoven, Uden, Netherlands
Lutetium-177-PSMA-617 in Oligo-metastatic Hormone Sensitive Prostate Cancer
- First Posted Date
- 2020-06-23
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Radboud University Medical Center
- Target Recruit Count
- 58
- Registration Number
- NCT04443062
- Locations
- π¨πΎ
German Oncology Center, Limassol, Cyprus
π³π±Amsterdam UMC, Amsterdam, Netherlands
π³π±University Medical Center Groningen, Groningen, Netherlands
Β© Copyright 2025. All Rights Reserved by MedPath